Cargando…
ABCD(2) risk score does not predict the presence of cerebral microemboli in patients with hyper-acute symptomatic critical carotid artery stenosis
INTRODUCTION: ABCD(2) risk score and cerebral microemboli detected by transcranial Doppler (TCD) have been separately shown to the predict risk of recurrent acute stroke. We studied whether ABCD(2) risk score predicts cerebral microemboli in patients with hyper-acute symptomatic carotid artery steno...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600015/ https://www.ncbi.nlm.nih.gov/pubmed/28959490 http://dx.doi.org/10.1136/svn-2017-000073 |
_version_ | 1783264169027436544 |
---|---|
author | Saedon, Mahmud Hutchinson, Charles E Imray, Christopher H E Singer, Donald R J |
author_facet | Saedon, Mahmud Hutchinson, Charles E Imray, Christopher H E Singer, Donald R J |
author_sort | Saedon, Mahmud |
collection | PubMed |
description | INTRODUCTION: ABCD(2) risk score and cerebral microemboli detected by transcranial Doppler (TCD) have been separately shown to the predict risk of recurrent acute stroke. We studied whether ABCD(2) risk score predicts cerebral microemboli in patients with hyper-acute symptomatic carotid artery stenosis. PARTICIPANTS AND METHODS: We studied 206 patients presenting within 2 weeks of transient ischaemic attack or minor stroke and found to have critical carotid artery stenosis (≥50%). 86 patients (age 70±1 (SEM: years), 58 men, 83 Caucasian) had evidence of microemboli; 72 (84%) of these underwent carotid endarterectomy (CEA). 120 patients (age 72±1 years, 91 men, 113 Caucasian) did not have microemboli detected; 102 (85%) of these underwent CEA. Data were analysed using X (2) and Mann–Whitney U tests and receiver operating characteristic (ROC) curves. RESULTS: 140/206 (68%: 95% CI 61.63 to 74.37) patients with hyper-acute symptomatic critical carotid stenosis had an ABCD(2) risk score ≥4. There was no significant difference in the NICE red flag criterion for early assessment (ABCD(2) risk score ≥4) for patients with cerebral microemboli versus those without microemboli (59/86 vs 81/120 patients: OR 1.05 ABCD(2) risk score ≥4 (95% CI 0.58 to 1.90, p=0.867)). The ABCD(2) risk score was <4 in 27 of 86 (31%: 95% CI 21 to 41) embolising patients and in 39 of 120 (31%: 95% CI 23 to 39) without cerebral microemboli. After adjusting for pre-neurological event antiplatelet treatment (APT), area under the curve (AUC) of ROC for ABCD(2) risk score showed no prediction of cerebral microemboli (no pre-event APT, n=57: AUC 0.45 (95% CI 0.29 to 0.60, p=0.531); pre-event APT, n=147: AUC 0.51 (95% CI 0.42 to 0.60, p=0.804)). CONCLUSIONS: The ABCD(2) score did not predict the presence of cerebral microemboli or carotid disease in over one-quarter of patients with symptomatic critical carotid artery stenosis. On the basis of NICE guidelines (refer early if ABCD(2) ≥4), assessment of high stroke risk based on ABCD(2) scoring may lead to inappropriate delay in urgent treatment in many patients. |
format | Online Article Text |
id | pubmed-5600015 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-56000152017-09-28 ABCD(2) risk score does not predict the presence of cerebral microemboli in patients with hyper-acute symptomatic critical carotid artery stenosis Saedon, Mahmud Hutchinson, Charles E Imray, Christopher H E Singer, Donald R J Stroke Vasc Neurol Original Article INTRODUCTION: ABCD(2) risk score and cerebral microemboli detected by transcranial Doppler (TCD) have been separately shown to the predict risk of recurrent acute stroke. We studied whether ABCD(2) risk score predicts cerebral microemboli in patients with hyper-acute symptomatic carotid artery stenosis. PARTICIPANTS AND METHODS: We studied 206 patients presenting within 2 weeks of transient ischaemic attack or minor stroke and found to have critical carotid artery stenosis (≥50%). 86 patients (age 70±1 (SEM: years), 58 men, 83 Caucasian) had evidence of microemboli; 72 (84%) of these underwent carotid endarterectomy (CEA). 120 patients (age 72±1 years, 91 men, 113 Caucasian) did not have microemboli detected; 102 (85%) of these underwent CEA. Data were analysed using X (2) and Mann–Whitney U tests and receiver operating characteristic (ROC) curves. RESULTS: 140/206 (68%: 95% CI 61.63 to 74.37) patients with hyper-acute symptomatic critical carotid stenosis had an ABCD(2) risk score ≥4. There was no significant difference in the NICE red flag criterion for early assessment (ABCD(2) risk score ≥4) for patients with cerebral microemboli versus those without microemboli (59/86 vs 81/120 patients: OR 1.05 ABCD(2) risk score ≥4 (95% CI 0.58 to 1.90, p=0.867)). The ABCD(2) risk score was <4 in 27 of 86 (31%: 95% CI 21 to 41) embolising patients and in 39 of 120 (31%: 95% CI 23 to 39) without cerebral microemboli. After adjusting for pre-neurological event antiplatelet treatment (APT), area under the curve (AUC) of ROC for ABCD(2) risk score showed no prediction of cerebral microemboli (no pre-event APT, n=57: AUC 0.45 (95% CI 0.29 to 0.60, p=0.531); pre-event APT, n=147: AUC 0.51 (95% CI 0.42 to 0.60, p=0.804)). CONCLUSIONS: The ABCD(2) score did not predict the presence of cerebral microemboli or carotid disease in over one-quarter of patients with symptomatic critical carotid artery stenosis. On the basis of NICE guidelines (refer early if ABCD(2) ≥4), assessment of high stroke risk based on ABCD(2) scoring may lead to inappropriate delay in urgent treatment in many patients. BMJ Publishing Group 2017-03-17 /pmc/articles/PMC5600015/ /pubmed/28959490 http://dx.doi.org/10.1136/svn-2017-000073 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Original Article Saedon, Mahmud Hutchinson, Charles E Imray, Christopher H E Singer, Donald R J ABCD(2) risk score does not predict the presence of cerebral microemboli in patients with hyper-acute symptomatic critical carotid artery stenosis |
title | ABCD(2) risk score does not predict the presence of cerebral microemboli in patients with hyper-acute symptomatic critical carotid artery stenosis |
title_full | ABCD(2) risk score does not predict the presence of cerebral microemboli in patients with hyper-acute symptomatic critical carotid artery stenosis |
title_fullStr | ABCD(2) risk score does not predict the presence of cerebral microemboli in patients with hyper-acute symptomatic critical carotid artery stenosis |
title_full_unstemmed | ABCD(2) risk score does not predict the presence of cerebral microemboli in patients with hyper-acute symptomatic critical carotid artery stenosis |
title_short | ABCD(2) risk score does not predict the presence of cerebral microemboli in patients with hyper-acute symptomatic critical carotid artery stenosis |
title_sort | abcd(2) risk score does not predict the presence of cerebral microemboli in patients with hyper-acute symptomatic critical carotid artery stenosis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600015/ https://www.ncbi.nlm.nih.gov/pubmed/28959490 http://dx.doi.org/10.1136/svn-2017-000073 |
work_keys_str_mv | AT saedonmahmud abcd2riskscoredoesnotpredictthepresenceofcerebralmicroemboliinpatientswithhyperacutesymptomaticcriticalcarotidarterystenosis AT hutchinsoncharlese abcd2riskscoredoesnotpredictthepresenceofcerebralmicroemboliinpatientswithhyperacutesymptomaticcriticalcarotidarterystenosis AT imraychristopherhe abcd2riskscoredoesnotpredictthepresenceofcerebralmicroemboliinpatientswithhyperacutesymptomaticcriticalcarotidarterystenosis AT singerdonaldrj abcd2riskscoredoesnotpredictthepresenceofcerebralmicroemboliinpatientswithhyperacutesymptomaticcriticalcarotidarterystenosis |